Moderna Inc (MRNA) has fallen Tuesday morning, with the stock losing -2.55% in pre-market trading to 199.5. MRNA's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 91% of stocks. Moderna Inc has fallen 30.55% over the past month, closing at $268.14 on December 21. During this period of time, the stock fell as low as $204.73 and as high as $281.30. MRNA has an average analyst recommendation of Buy. The company has an average price target of $257.23.
MRNA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on MRNA!